<\/p>\n
Ondem Injektion<\/strong> indeholder ondansetron 2 mg\/ml<\/strong> in 2 ml ampoules (4 mg total) — a selective serotonin 5-HT3-receptorantagonist<\/strong> used in hospitals to prevent and treat kemoterapi-induceret<\/strong>, str\u00e5lingsinduceret<\/strong>, og post-operative nausea and vomiting (PONV)<\/strong>. Administered by a healthcare professional intravenously (slow push or short infusion) or intramuscularly. Onset within 5–10 minutes IV. Manufactured by Alkem Laboratories — the generic equivalent of Zofran injection. FDA single-dose cap 16 mg IV<\/strong> due to QT signal at higher doses.<\/p>\n<\/div>\n \ud83d\udce6 Hver ordre er d\u00e6kket af vores Reshipment Assurance Policy<\/strong><\/a> \u2014 hvis din pakke ikke ankommer inden for 20 hverdage, sender vi en erstatning.<\/p>\n Vores generiske medicin kommer fra WHO-GMP certificerede producenter og sendes verdensomsp\u00e6ndende i diskret, neutral emballage \u2014 ingen medicinnavn p\u00e5 pakkens ydre. Kortbetalinger h\u00e5ndteres af en reguleret processor (kontoudtogsbeskrivelser inkluderer en reguleret betalingsprocessor \u2014 aldrig \u201cMedsBase\u201d eller medicinnavn). Crypto og SEPA bankoverf\u00f8rsel accepteres ogs\u00e5. Hver ordre er d\u00e6kket af vores Reshipment Assurance Policy.<\/p>\n Ondem Injection is supplied from a WHO-GMP certificeret producent<\/strong>. Hver ordre sendes diskret over hele verden og er d\u00e6kket af vores Reshipment Assurance Policy<\/a> — if it does not arrive within 20 business days, we reship at no cost. Ondem Injection is the global standard parenteral 5-HT3 antagonist for inpatient antiemesis. Alkem is one of India’s largest WHO-GMP injectable manufacturers and the formulation is bioequivalent to the reference brand.<\/p>\n Chemotherapy, radiation, and surgical stress damage gut enterochromaffin cells, releasing massive amounts of serotonin (5-HT)<\/strong>. The serotonin binds 5-HT3 receptors on vagal afferents and on the chemoreceptor trigger zone (area postrema), generating the strongest known oral\/intestinal emetic stimulus. Ondansetron is a highly selective antagonist at the 5-HT3 receptor — it interrupts this signal at both peripheral and central sites without affecting D2, H1, muscarinic, or alpha-adrenergic receptors. The clean receptor profile explains the absence of sedation, extrapyramidal reactions, and anticholinergic side effects that limit older antiemetics like prochlorperazine and metoclopramide.<\/p>\nHvorfor bestille fra MedsBase<\/h3>\n
Hvorfor bestille fra MedsBase<\/h3>\n
Virkningsmekanisme<\/h2>\n
Indikationer<\/h2>\n
\n
Dosis<\/h2>\n